nodes	percent_of_prediction	percent_of_DWPC	metapath
Pindolol—Conduction disorder—Vandetanib—thyroid cancer	0.101	0.102	CcSEcCtD
Pindolol—Musculoskeletal disorder—Vandetanib—thyroid cancer	0.0595	0.06	CcSEcCtD
Pindolol—Cardiac failure—Vandetanib—thyroid cancer	0.0158	0.0159	CcSEcCtD
Pindolol—Lethargy—Vandetanib—thyroid cancer	0.0157	0.0159	CcSEcCtD
Pindolol—Bronchospasm—Vandetanib—thyroid cancer	0.0131	0.0132	CcSEcCtD
Pindolol—Pollakiuria—Vandetanib—thyroid cancer	0.0123	0.0124	CcSEcCtD
Pindolol—Depression—Vandetanib—thyroid cancer	0.0118	0.012	CcSEcCtD
Pindolol—Conjunctivitis—Vandetanib—thyroid cancer	0.0115	0.0117	CcSEcCtD
Pindolol—Cardiac failure congestive—Sorafenib—thyroid cancer	0.0115	0.0116	CcSEcCtD
Pindolol—Bradycardia—Vandetanib—thyroid cancer	0.0109	0.011	CcSEcCtD
Pindolol—Cardiac failure—Sorafenib—thyroid cancer	0.0107	0.0108	CcSEcCtD
Pindolol—Visual impairment—Vandetanib—thyroid cancer	0.0103	0.0104	CcSEcCtD
Pindolol—Cardiac disorder—Vandetanib—thyroid cancer	0.0099	0.00999	CcSEcCtD
Pindolol—Angiopathy—Vandetanib—thyroid cancer	0.00968	0.00977	CcSEcCtD
Pindolol—Mediastinal disorder—Vandetanib—thyroid cancer	0.00961	0.0097	CcSEcCtD
Pindolol—Mental disorder—Vandetanib—thyroid cancer	0.00934	0.00943	CcSEcCtD
Pindolol—Muscle spasms—Vandetanib—thyroid cancer	0.00893	0.00901	CcSEcCtD
Pindolol—Transaminases increased—Epirubicin—thyroid cancer	0.0087	0.00878	CcSEcCtD
Pindolol—Tremor—Vandetanib—thyroid cancer	0.0087	0.00878	CcSEcCtD
Pindolol—Abdominal discomfort—Sorafenib—thyroid cancer	0.00862	0.0087	CcSEcCtD
Pindolol—Psoriasis—Epirubicin—thyroid cancer	0.00842	0.0085	CcSEcCtD
Pindolol—Erectile dysfunction—Sorafenib—thyroid cancer	0.00828	0.00835	CcSEcCtD
Pindolol—Keratitis—Epirubicin—thyroid cancer	0.00816	0.00824	CcSEcCtD
Pindolol—Loss of consciousness—Vandetanib—thyroid cancer	0.00816	0.00824	CcSEcCtD
Pindolol—Transaminases increased—Doxorubicin—thyroid cancer	0.00805	0.00813	CcSEcCtD
Pindolol—Arthralgia—Vandetanib—thyroid cancer	0.0079	0.00798	CcSEcCtD
Pindolol—Chest pain—Vandetanib—thyroid cancer	0.0079	0.00798	CcSEcCtD
Pindolol—Anxiety—Vandetanib—thyroid cancer	0.00788	0.00795	CcSEcCtD
Pindolol—Psoriasis—Doxorubicin—thyroid cancer	0.00779	0.00787	CcSEcCtD
Pindolol—Dry mouth—Vandetanib—thyroid cancer	0.00773	0.0078	CcSEcCtD
Pindolol—Oedema—Vandetanib—thyroid cancer	0.00758	0.00765	CcSEcCtD
Pindolol—Keratitis—Doxorubicin—thyroid cancer	0.00755	0.00762	CcSEcCtD
Pindolol—Nervous system disorder—Vandetanib—thyroid cancer	0.00743	0.0075	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.0069	0.00697	CcSEcCtD
Pindolol—Insomnia—Vandetanib—thyroid cancer	0.00685	0.00692	CcSEcCtD
Pindolol—Paraesthesia—Vandetanib—thyroid cancer	0.0068	0.00687	CcSEcCtD
Pindolol—Dyspnoea—Vandetanib—thyroid cancer	0.00675	0.00682	CcSEcCtD
Pindolol—Tinnitus—Sorafenib—thyroid cancer	0.00671	0.00677	CcSEcCtD
Pindolol—Cardiac disorder—Sorafenib—thyroid cancer	0.00668	0.00674	CcSEcCtD
Pindolol—Dyspepsia—Vandetanib—thyroid cancer	0.00667	0.00673	CcSEcCtD
Pindolol—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00654	0.0066	CcSEcCtD
Pindolol—Fatigue—Vandetanib—thyroid cancer	0.00653	0.00659	CcSEcCtD
Pindolol—Angiopathy—Sorafenib—thyroid cancer	0.00653	0.00659	CcSEcCtD
Pindolol—Mediastinal disorder—Sorafenib—thyroid cancer	0.00648	0.00654	CcSEcCtD
Pindolol—Pain—Vandetanib—thyroid cancer	0.00648	0.00654	CcSEcCtD
Pindolol—Constipation—Vandetanib—thyroid cancer	0.00648	0.00654	CcSEcCtD
Pindolol—Mental disorder—Sorafenib—thyroid cancer	0.0063	0.00636	CcSEcCtD
Pindolol—Gastrointestinal pain—Vandetanib—thyroid cancer	0.0062	0.00625	CcSEcCtD
Pindolol—Muscle spasms—Sorafenib—thyroid cancer	0.00602	0.00608	CcSEcCtD
Pindolol—Abdominal pain—Vandetanib—thyroid cancer	0.00599	0.00605	CcSEcCtD
Pindolol—Syncope—Sorafenib—thyroid cancer	0.00562	0.00567	CcSEcCtD
Pindolol—Loss of consciousness—Sorafenib—thyroid cancer	0.0055	0.00556	CcSEcCtD
Pindolol—Atrioventricular block—Epirubicin—thyroid cancer	0.00546	0.00551	CcSEcCtD
Pindolol—Asthenia—Vandetanib—thyroid cancer	0.00544	0.00549	CcSEcCtD
Pindolol—Pruritus—Vandetanib—thyroid cancer	0.00536	0.00541	CcSEcCtD
Pindolol—Myalgia—Sorafenib—thyroid cancer	0.00533	0.00538	CcSEcCtD
Pindolol—Arthralgia—Sorafenib—thyroid cancer	0.00533	0.00538	CcSEcCtD
Pindolol—Abnormal dreams—Epirubicin—thyroid cancer	0.00523	0.00528	CcSEcCtD
Pindolol—Dry mouth—Sorafenib—thyroid cancer	0.00521	0.00526	CcSEcCtD
Pindolol—Diarrhoea—Vandetanib—thyroid cancer	0.00518	0.00523	CcSEcCtD
Pindolol—Atrioventricular block—Doxorubicin—thyroid cancer	0.00505	0.0051	CcSEcCtD
Pindolol—Shock—Sorafenib—thyroid cancer	0.00503	0.00508	CcSEcCtD
Pindolol—Nervous system disorder—Sorafenib—thyroid cancer	0.00501	0.00506	CcSEcCtD
Pindolol—Dizziness—Vandetanib—thyroid cancer	0.00501	0.00506	CcSEcCtD
Pindolol—Abnormal dreams—Doxorubicin—thyroid cancer	0.00484	0.00489	CcSEcCtD
Pindolol—Vomiting—Vandetanib—thyroid cancer	0.00482	0.00486	CcSEcCtD
Pindolol—Rash—Vandetanib—thyroid cancer	0.00478	0.00482	CcSEcCtD
Pindolol—Dermatitis—Vandetanib—thyroid cancer	0.00477	0.00482	CcSEcCtD
Pindolol—Headache—Vandetanib—thyroid cancer	0.00475	0.00479	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00466	0.0047	CcSEcCtD
Pindolol—Dyspnoea—Sorafenib—thyroid cancer	0.00456	0.0046	CcSEcCtD
Pindolol—Nausea—Vandetanib—thyroid cancer	0.0045	0.00454	CcSEcCtD
Pindolol—Dyspepsia—Sorafenib—thyroid cancer	0.0045	0.00454	CcSEcCtD
Pindolol—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00441	0.00445	CcSEcCtD
Pindolol—Fatigue—Sorafenib—thyroid cancer	0.00441	0.00445	CcSEcCtD
Pindolol—Pain—Sorafenib—thyroid cancer	0.00437	0.00441	CcSEcCtD
Pindolol—Constipation—Sorafenib—thyroid cancer	0.00437	0.00441	CcSEcCtD
Pindolol—Cardiac failure congestive—Epirubicin—thyroid cancer	0.00424	0.00428	CcSEcCtD
Pindolol—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00418	0.00422	CcSEcCtD
Pindolol—Hot flush—Epirubicin—thyroid cancer	0.00411	0.00415	CcSEcCtD
Pindolol—Menopausal symptoms—Epirubicin—thyroid cancer	0.00407	0.00411	CcSEcCtD
Pindolol—Abdominal pain—Sorafenib—thyroid cancer	0.00404	0.00408	CcSEcCtD
Pindolol—Cardiac failure—Epirubicin—thyroid cancer	0.00394	0.00397	CcSEcCtD
Pindolol—Lethargy—Epirubicin—thyroid cancer	0.00392	0.00396	CcSEcCtD
Pindolol—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.00392	0.00396	CcSEcCtD
Pindolol—Hot flush—Doxorubicin—thyroid cancer	0.0038	0.00384	CcSEcCtD
Pindolol—Menopausal symptoms—Doxorubicin—thyroid cancer	0.00377	0.0038	CcSEcCtD
Pindolol—Asthenia—Sorafenib—thyroid cancer	0.00367	0.0037	CcSEcCtD
Pindolol—Cardiac failure—Doxorubicin—thyroid cancer	0.00364	0.00368	CcSEcCtD
Pindolol—Lethargy—Doxorubicin—thyroid cancer	0.00363	0.00366	CcSEcCtD
Pindolol—Pruritus—Sorafenib—thyroid cancer	0.00362	0.00365	CcSEcCtD
Pindolol—Orthostatic hypotension—Epirubicin—thyroid cancer	0.00351	0.00354	CcSEcCtD
Pindolol—Diarrhoea—Sorafenib—thyroid cancer	0.0035	0.00353	CcSEcCtD
Pindolol—Dizziness—Sorafenib—thyroid cancer	0.00338	0.00341	CcSEcCtD
Pindolol—Vomiting—Sorafenib—thyroid cancer	0.00325	0.00328	CcSEcCtD
Pindolol—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.00325	0.00328	CcSEcCtD
Pindolol—Rash—Sorafenib—thyroid cancer	0.00322	0.00325	CcSEcCtD
Pindolol—Dermatitis—Sorafenib—thyroid cancer	0.00322	0.00325	CcSEcCtD
Pindolol—Headache—Sorafenib—thyroid cancer	0.0032	0.00323	CcSEcCtD
Pindolol—Pollakiuria—Epirubicin—thyroid cancer	0.00307	0.0031	CcSEcCtD
Pindolol—Nausea—Sorafenib—thyroid cancer	0.00304	0.00306	CcSEcCtD
Pindolol—Weight increased—Epirubicin—thyroid cancer	0.00302	0.00305	CcSEcCtD
Pindolol—Drowsiness—Epirubicin—thyroid cancer	0.00296	0.00299	CcSEcCtD
Pindolol—Conjunctivitis—Epirubicin—thyroid cancer	0.00288	0.00291	CcSEcCtD
Pindolol—Sweating—Epirubicin—thyroid cancer	0.00284	0.00287	CcSEcCtD
Pindolol—Pollakiuria—Doxorubicin—thyroid cancer	0.00284	0.00287	CcSEcCtD
Pindolol—Weight increased—Doxorubicin—thyroid cancer	0.0028	0.00282	CcSEcCtD
Pindolol—Drowsiness—Doxorubicin—thyroid cancer	0.00274	0.00277	CcSEcCtD
Pindolol—Bradycardia—Epirubicin—thyroid cancer	0.00271	0.00273	CcSEcCtD
Pindolol—Conjunctivitis—Doxorubicin—thyroid cancer	0.00266	0.00269	CcSEcCtD
Pindolol—Sweating—Doxorubicin—thyroid cancer	0.00263	0.00265	CcSEcCtD
Pindolol—Visual impairment—Epirubicin—thyroid cancer	0.00256	0.00259	CcSEcCtD
Pindolol—Bradycardia—Doxorubicin—thyroid cancer	0.0025	0.00253	CcSEcCtD
Pindolol—Tinnitus—Epirubicin—thyroid cancer	0.00248	0.0025	CcSEcCtD
Pindolol—Cardiac disorder—Epirubicin—thyroid cancer	0.00247	0.00249	CcSEcCtD
Pindolol—Angiopathy—Epirubicin—thyroid cancer	0.00241	0.00243	CcSEcCtD
Pindolol—Mediastinal disorder—Epirubicin—thyroid cancer	0.0024	0.00242	CcSEcCtD
Pindolol—Visual impairment—Doxorubicin—thyroid cancer	0.00237	0.00239	CcSEcCtD
Pindolol—Mental disorder—Epirubicin—thyroid cancer	0.00233	0.00235	CcSEcCtD
Pindolol—Tinnitus—Doxorubicin—thyroid cancer	0.00229	0.00231	CcSEcCtD
Pindolol—Cardiac disorder—Doxorubicin—thyroid cancer	0.00228	0.0023	CcSEcCtD
Pindolol—Flatulence—Epirubicin—thyroid cancer	0.00228	0.0023	CcSEcCtD
Pindolol—Tension—Epirubicin—thyroid cancer	0.00227	0.00229	CcSEcCtD
Pindolol—Nervousness—Epirubicin—thyroid cancer	0.00225	0.00227	CcSEcCtD
Pindolol—Angiopathy—Doxorubicin—thyroid cancer	0.00223	0.00225	CcSEcCtD
Pindolol—Muscle spasms—Epirubicin—thyroid cancer	0.00223	0.00225	CcSEcCtD
Pindolol—Mediastinal disorder—Doxorubicin—thyroid cancer	0.00222	0.00224	CcSEcCtD
Pindolol—Mental disorder—Doxorubicin—thyroid cancer	0.00216	0.00218	CcSEcCtD
Pindolol—Flatulence—Doxorubicin—thyroid cancer	0.00211	0.00213	CcSEcCtD
Pindolol—Tension—Doxorubicin—thyroid cancer	0.0021	0.00212	CcSEcCtD
Pindolol—Nervousness—Doxorubicin—thyroid cancer	0.00208	0.0021	CcSEcCtD
Pindolol—Vertigo—Epirubicin—thyroid cancer	0.00208	0.0021	CcSEcCtD
Pindolol—Syncope—Epirubicin—thyroid cancer	0.00208	0.00209	CcSEcCtD
Pindolol—Muscle spasms—Doxorubicin—thyroid cancer	0.00206	0.00208	CcSEcCtD
Pindolol—Palpitations—Epirubicin—thyroid cancer	0.00205	0.00206	CcSEcCtD
Pindolol—Loss of consciousness—Epirubicin—thyroid cancer	0.00203	0.00205	CcSEcCtD
Pindolol—Chest pain—Epirubicin—thyroid cancer	0.00197	0.00199	CcSEcCtD
Pindolol—Myalgia—Epirubicin—thyroid cancer	0.00197	0.00199	CcSEcCtD
Pindolol—Arthralgia—Epirubicin—thyroid cancer	0.00197	0.00199	CcSEcCtD
Pindolol—Anxiety—Epirubicin—thyroid cancer	0.00196	0.00198	CcSEcCtD
Pindolol—Dry mouth—Epirubicin—thyroid cancer	0.00193	0.00194	CcSEcCtD
Pindolol—Vertigo—Doxorubicin—thyroid cancer	0.00192	0.00194	CcSEcCtD
Pindolol—Syncope—Doxorubicin—thyroid cancer	0.00192	0.00194	CcSEcCtD
Pindolol—Confusional state—Epirubicin—thyroid cancer	0.0019	0.00192	CcSEcCtD
Pindolol—Palpitations—Doxorubicin—thyroid cancer	0.00189	0.00191	CcSEcCtD
Pindolol—Oedema—Epirubicin—thyroid cancer	0.00189	0.00191	CcSEcCtD
Pindolol—Loss of consciousness—Doxorubicin—thyroid cancer	0.00188	0.0019	CcSEcCtD
Pindolol—Shock—Epirubicin—thyroid cancer	0.00186	0.00188	CcSEcCtD
Pindolol—Nervous system disorder—Epirubicin—thyroid cancer	0.00185	0.00187	CcSEcCtD
Pindolol—Tachycardia—Epirubicin—thyroid cancer	0.00184	0.00186	CcSEcCtD
Pindolol—Hyperhidrosis—Epirubicin—thyroid cancer	0.00183	0.00184	CcSEcCtD
Pindolol—Arthralgia—Doxorubicin—thyroid cancer	0.00182	0.00184	CcSEcCtD
Pindolol—Chest pain—Doxorubicin—thyroid cancer	0.00182	0.00184	CcSEcCtD
Pindolol—Myalgia—Doxorubicin—thyroid cancer	0.00182	0.00184	CcSEcCtD
Pindolol—Anxiety—Doxorubicin—thyroid cancer	0.00182	0.00183	CcSEcCtD
Pindolol—Dry mouth—Doxorubicin—thyroid cancer	0.00178	0.0018	CcSEcCtD
Pindolol—Hypotension—Epirubicin—thyroid cancer	0.00176	0.00178	CcSEcCtD
Pindolol—Confusional state—Doxorubicin—thyroid cancer	0.00176	0.00178	CcSEcCtD
Pindolol—Oedema—Doxorubicin—thyroid cancer	0.00175	0.00176	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00172	0.00174	CcSEcCtD
Pindolol—Shock—Doxorubicin—thyroid cancer	0.00172	0.00174	CcSEcCtD
Pindolol—Nervous system disorder—Doxorubicin—thyroid cancer	0.00171	0.00173	CcSEcCtD
Pindolol—Insomnia—Epirubicin—thyroid cancer	0.00171	0.00172	CcSEcCtD
Pindolol—Tachycardia—Doxorubicin—thyroid cancer	0.00171	0.00172	CcSEcCtD
Pindolol—Paraesthesia—Epirubicin—thyroid cancer	0.0017	0.00171	CcSEcCtD
Pindolol—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00169	0.00171	CcSEcCtD
Pindolol—Dyspnoea—Epirubicin—thyroid cancer	0.00168	0.0017	CcSEcCtD
Pindolol—Somnolence—Epirubicin—thyroid cancer	0.00168	0.00169	CcSEcCtD
Pindolol—Dyspepsia—Epirubicin—thyroid cancer	0.00166	0.00168	CcSEcCtD
Pindolol—Hypotension—Doxorubicin—thyroid cancer	0.00163	0.00165	CcSEcCtD
Pindolol—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00163	0.00165	CcSEcCtD
Pindolol—Fatigue—Epirubicin—thyroid cancer	0.00163	0.00164	CcSEcCtD
Pindolol—Pain—Epirubicin—thyroid cancer	0.00162	0.00163	CcSEcCtD
Pindolol—Constipation—Epirubicin—thyroid cancer	0.00162	0.00163	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.00159	0.00161	CcSEcCtD
Pindolol—Insomnia—Doxorubicin—thyroid cancer	0.00158	0.0016	CcSEcCtD
Pindolol—Paraesthesia—Doxorubicin—thyroid cancer	0.00157	0.00158	CcSEcCtD
Pindolol—Dyspnoea—Doxorubicin—thyroid cancer	0.00156	0.00157	CcSEcCtD
Pindolol—Feeling abnormal—Epirubicin—thyroid cancer	0.00156	0.00157	CcSEcCtD
Pindolol—Somnolence—Doxorubicin—thyroid cancer	0.00155	0.00157	CcSEcCtD
Pindolol—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00154	0.00156	CcSEcCtD
Pindolol—Dyspepsia—Doxorubicin—thyroid cancer	0.00154	0.00155	CcSEcCtD
Pindolol—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.00151	0.00152	CcSEcCtD
Pindolol—Fatigue—Doxorubicin—thyroid cancer	0.00151	0.00152	CcSEcCtD
Pindolol—Pain—Doxorubicin—thyroid cancer	0.00149	0.00151	CcSEcCtD
Pindolol—Constipation—Doxorubicin—thyroid cancer	0.00149	0.00151	CcSEcCtD
Pindolol—Abdominal pain—Epirubicin—thyroid cancer	0.00149	0.00151	CcSEcCtD
Pindolol—Feeling abnormal—Doxorubicin—thyroid cancer	0.00144	0.00145	CcSEcCtD
Pindolol—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00143	0.00144	CcSEcCtD
Pindolol—Abdominal pain—Doxorubicin—thyroid cancer	0.00138	0.00139	CcSEcCtD
Pindolol—Asthenia—Epirubicin—thyroid cancer	0.00136	0.00137	CcSEcCtD
Pindolol—Pruritus—Epirubicin—thyroid cancer	0.00134	0.00135	CcSEcCtD
Pindolol—Diarrhoea—Epirubicin—thyroid cancer	0.00129	0.0013	CcSEcCtD
Pindolol—Asthenia—Doxorubicin—thyroid cancer	0.00125	0.00127	CcSEcCtD
Pindolol—Dizziness—Epirubicin—thyroid cancer	0.00125	0.00126	CcSEcCtD
Pindolol—Pruritus—Doxorubicin—thyroid cancer	0.00124	0.00125	CcSEcCtD
Pindolol—Vomiting—Epirubicin—thyroid cancer	0.0012	0.00121	CcSEcCtD
Pindolol—Diarrhoea—Doxorubicin—thyroid cancer	0.0012	0.00121	CcSEcCtD
Pindolol—Rash—Epirubicin—thyroid cancer	0.00119	0.0012	CcSEcCtD
Pindolol—Dermatitis—Epirubicin—thyroid cancer	0.00119	0.0012	CcSEcCtD
Pindolol—Headache—Epirubicin—thyroid cancer	0.00118	0.00119	CcSEcCtD
Pindolol—Dizziness—Doxorubicin—thyroid cancer	0.00116	0.00117	CcSEcCtD
Pindolol—Nausea—Epirubicin—thyroid cancer	0.00112	0.00113	CcSEcCtD
Pindolol—Vomiting—Doxorubicin—thyroid cancer	0.00111	0.00112	CcSEcCtD
Pindolol—Rash—Doxorubicin—thyroid cancer	0.0011	0.00111	CcSEcCtD
Pindolol—Dermatitis—Doxorubicin—thyroid cancer	0.0011	0.00111	CcSEcCtD
Pindolol—Headache—Doxorubicin—thyroid cancer	0.00109	0.00111	CcSEcCtD
Pindolol—Nausea—Doxorubicin—thyroid cancer	0.00104	0.00105	CcSEcCtD
Pindolol—ADRB3—GPCR ligand binding—CALCB—thyroid cancer	0.000166	0.018	CbGpPWpGaD
Pindolol—HTR1A—SIDS Susceptibility Pathways—RET—thyroid cancer	0.000159	0.0172	CbGpPWpGaD
Pindolol—ADRB3—G alpha (s) signalling events—CALCA—thyroid cancer	0.000158	0.0171	CbGpPWpGaD
Pindolol—HTR1A—SIDS Susceptibility Pathways—THRB—thyroid cancer	0.000148	0.016	CbGpPWpGaD
Pindolol—ADRB1—G alpha (s) signalling events—TSHR—thyroid cancer	0.000126	0.0136	CbGpPWpGaD
Pindolol—HTR1B—GPCR ligand binding—CALCB—thyroid cancer	0.000124	0.0134	CbGpPWpGaD
Pindolol—ADRB2—G alpha (s) signalling events—TSHR—thyroid cancer	0.000123	0.0133	CbGpPWpGaD
Pindolol—ADRB1—Calcium Regulation in the Cardiac Cell—PRKAR1A—thyroid cancer	0.000107	0.0115	CbGpPWpGaD
Pindolol—ADRB2—Calcium Regulation in the Cardiac Cell—PRKAR1A—thyroid cancer	0.000104	0.0113	CbGpPWpGaD
Pindolol—CYP2D6—Metapathway biotransformation—CHST14—thyroid cancer	0.000101	0.0109	CbGpPWpGaD
Pindolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—TSHR—thyroid cancer	0.000101	0.0109	CbGpPWpGaD
Pindolol—ADRB1—GPCR ligand binding—CALCB—thyroid cancer	9.85e-05	0.0107	CbGpPWpGaD
Pindolol—HTR1A—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	9.84e-05	0.0106	CbGpPWpGaD
Pindolol—ADRB2—GPCR ligand binding—CALCB—thyroid cancer	9.64e-05	0.0104	CbGpPWpGaD
Pindolol—HTR1A—GPCR ligand binding—CALCB—thyroid cancer	9.42e-05	0.0102	CbGpPWpGaD
Pindolol—ADRB1—G alpha (s) signalling events—CALCA—thyroid cancer	9.41e-05	0.0102	CbGpPWpGaD
Pindolol—ADRB3—GPCR downstream signaling—CALCB—thyroid cancer	9.38e-05	0.0101	CbGpPWpGaD
Pindolol—ADRB2—G alpha (s) signalling events—CALCA—thyroid cancer	9.2e-05	0.00995	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—CALCB—thyroid cancer	8.52e-05	0.00921	CbGpPWpGaD
Pindolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	7.85e-05	0.00849	CbGpPWpGaD
Pindolol—HTR1A—SIDS Susceptibility Pathways—SST—thyroid cancer	7.78e-05	0.00841	CbGpPWpGaD
Pindolol—ADRB3—GPCR ligand binding—TSHR—thyroid cancer	7.69e-05	0.00831	CbGpPWpGaD
Pindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—TSHR—thyroid cancer	7.52e-05	0.00813	CbGpPWpGaD
Pindolol—HTR1B—G alpha (i) signalling events—SST—thyroid cancer	7.36e-05	0.00796	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—CALCB—thyroid cancer	6.99e-05	0.00756	CbGpPWpGaD
Pindolol—CYP2D6—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	6.92e-05	0.00748	CbGpPWpGaD
Pindolol—ADRB3—GPCR ligand binding—PTCH1—thyroid cancer	6.53e-05	0.00707	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—CALCB—thyroid cancer	6.35e-05	0.00687	CbGpPWpGaD
Pindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TSHR—thyroid cancer	5.99e-05	0.00648	CbGpPWpGaD
Pindolol—ADRB3—GPCR ligand binding—SST—thyroid cancer	5.98e-05	0.00646	CbGpPWpGaD
Pindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TSHR—thyroid cancer	5.86e-05	0.00634	CbGpPWpGaD
Pindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	5.85e-05	0.00633	CbGpPWpGaD
Pindolol—ADRB3—GPCR ligand binding—CALCA—thyroid cancer	5.75e-05	0.00622	CbGpPWpGaD
Pindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—TSHR—thyroid cancer	5.73e-05	0.0062	CbGpPWpGaD
Pindolol—HTR1B—GPCR ligand binding—TSHR—thyroid cancer	5.73e-05	0.00619	CbGpPWpGaD
Pindolol—CYP2D6—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	5.61e-05	0.00607	CbGpPWpGaD
Pindolol—HTR1A—G alpha (i) signalling events—SST—thyroid cancer	5.6e-05	0.00606	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—CALCB—thyroid cancer	5.57e-05	0.00602	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—CALCB—thyroid cancer	5.45e-05	0.00589	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—CALCB—thyroid cancer	5.33e-05	0.00576	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—CALCB—thyroid cancer	5.06e-05	0.00547	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—CALCB—thyroid cancer	5.03e-05	0.00544	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—CALCB—thyroid cancer	4.95e-05	0.00535	CbGpPWpGaD
Pindolol—HTR1B—GPCR ligand binding—PTCH1—thyroid cancer	4.87e-05	0.00527	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—CALCB—thyroid cancer	4.84e-05	0.00523	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—TRIM33—thyroid cancer	4.77e-05	0.00516	CbGpPWpGaD
Pindolol—HTR1A—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	4.67e-05	0.00505	CbGpPWpGaD
Pindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	4.66e-05	0.00504	CbGpPWpGaD
Pindolol—ADRB1—GPCR ligand binding—TSHR—thyroid cancer	4.56e-05	0.00493	CbGpPWpGaD
Pindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	4.56e-05	0.00493	CbGpPWpGaD
Pindolol—ADRB2—GPCR ligand binding—TSHR—thyroid cancer	4.46e-05	0.00483	CbGpPWpGaD
Pindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	4.46e-05	0.00482	CbGpPWpGaD
Pindolol—HTR1B—GPCR ligand binding—SST—thyroid cancer	4.45e-05	0.00482	CbGpPWpGaD
Pindolol—HTR1A—GPCR ligand binding—TSHR—thyroid cancer	4.36e-05	0.00472	CbGpPWpGaD
Pindolol—ADRB3—GPCR downstream signaling—TSHR—thyroid cancer	4.34e-05	0.0047	CbGpPWpGaD
Pindolol—HTR1B—GPCR ligand binding—CALCA—thyroid cancer	4.29e-05	0.00464	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—TSHR—thyroid cancer	3.94e-05	0.00427	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—PRKAR1A—thyroid cancer	3.88e-05	0.0042	CbGpPWpGaD
Pindolol—ADRB1—GPCR ligand binding—PTCH1—thyroid cancer	3.88e-05	0.00419	CbGpPWpGaD
Pindolol—ADRB2—GPCR ligand binding—PTCH1—thyroid cancer	3.79e-05	0.0041	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CALCB—thyroid cancer	3.75e-05	0.00406	CbGpPWpGaD
Pindolol—HTR1A—GPCR ligand binding—PTCH1—thyroid cancer	3.71e-05	0.00401	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—TRIM33—thyroid cancer	3.56e-05	0.00384	CbGpPWpGaD
Pindolol—ADRB1—GPCR ligand binding—SST—thyroid cancer	3.55e-05	0.00384	CbGpPWpGaD
Pindolol—ADRB2—GPCR ligand binding—SST—thyroid cancer	3.47e-05	0.00375	CbGpPWpGaD
Pindolol—ADRB1—GPCR ligand binding—CALCA—thyroid cancer	3.41e-05	0.00369	CbGpPWpGaD
Pindolol—HTR1A—GPCR ligand binding—SST—thyroid cancer	3.39e-05	0.00367	CbGpPWpGaD
Pindolol—ADRB3—GPCR downstream signaling—SST—thyroid cancer	3.38e-05	0.00365	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—PTCH1—thyroid cancer	3.35e-05	0.00363	CbGpPWpGaD
Pindolol—ADRB2—GPCR ligand binding—CALCA—thyroid cancer	3.34e-05	0.00361	CbGpPWpGaD
Pindolol—HTR1A—GPCR ligand binding—CALCA—thyroid cancer	3.27e-05	0.00353	CbGpPWpGaD
Pindolol—ADRB3—GPCR downstream signaling—CALCA—thyroid cancer	3.25e-05	0.00352	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—TSHR—thyroid cancer	3.24e-05	0.0035	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—TCF7L1—thyroid cancer	3.18e-05	0.00344	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—SST—thyroid cancer	3.07e-05	0.00332	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CALCB—thyroid cancer	2.99e-05	0.00323	CbGpPWpGaD
Pindolol—CYP2D6—Biological oxidations—RXRA—thyroid cancer	2.98e-05	0.00322	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—CALCA—thyroid cancer	2.95e-05	0.00319	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—TSHR—thyroid cancer	2.94e-05	0.00318	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CALCB—thyroid cancer	2.92e-05	0.00316	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—PRKAR1A—thyroid cancer	2.89e-05	0.00313	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CALCB—thyroid cancer	2.86e-05	0.00309	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—TRIM33—thyroid cancer	2.83e-05	0.00306	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—TRIM33—thyroid cancer	2.77e-05	0.003	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—TRIM33—thyroid cancer	2.71e-05	0.00293	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—CDK1—thyroid cancer	2.67e-05	0.00289	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—TSHR—thyroid cancer	2.58e-05	0.00279	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—TSHR—thyroid cancer	2.52e-05	0.00273	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—SST—thyroid cancer	2.52e-05	0.00272	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—PTCH1—thyroid cancer	2.5e-05	0.0027	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—TSHR—thyroid cancer	2.47e-05	0.00267	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—CALCA—thyroid cancer	2.42e-05	0.00262	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—TCF7L1—thyroid cancer	2.37e-05	0.00257	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—TSHR—thyroid cancer	2.34e-05	0.00253	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—TSHR—thyroid cancer	2.33e-05	0.00252	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—PRKAR1A—thyroid cancer	2.3e-05	0.00249	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—PRKAR1A—thyroid cancer	2.29e-05	0.00248	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—TSHR—thyroid cancer	2.29e-05	0.00248	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—SST—thyroid cancer	2.29e-05	0.00247	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—PRKAR1A—thyroid cancer	2.25e-05	0.00244	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—TSHR—thyroid cancer	2.24e-05	0.00242	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—PRKAR1A—thyroid cancer	2.2e-05	0.00238	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—CALCA—thyroid cancer	2.2e-05	0.00238	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—MEN1—thyroid cancer	2.19e-05	0.00237	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—MINPP1—thyroid cancer	2.19e-05	0.00237	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—SST—thyroid cancer	2e-05	0.00217	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—CDK1—thyroid cancer	1.99e-05	0.00215	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—PTCH1—thyroid cancer	1.99e-05	0.00215	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—PTCH1—thyroid cancer	1.98e-05	0.00214	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—SST—thyroid cancer	1.96e-05	0.00212	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—PTCH1—thyroid cancer	1.95e-05	0.00211	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—CALCA—thyroid cancer	1.93e-05	0.00209	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—SST—thyroid cancer	1.92e-05	0.00207	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—PTCH1—thyroid cancer	1.9e-05	0.00206	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—TCF7L1—thyroid cancer	1.89e-05	0.00204	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—CALCA—thyroid cancer	1.89e-05	0.00204	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—NDUFA13—thyroid cancer	1.86e-05	0.00201	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—TCF7L1—thyroid cancer	1.85e-05	0.002	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—CALCA—thyroid cancer	1.85e-05	0.002	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—SST—thyroid cancer	1.82e-05	0.00197	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—SST—thyroid cancer	1.81e-05	0.00196	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—TCF7L1—thyroid cancer	1.81e-05	0.00195	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—SST—thyroid cancer	1.78e-05	0.00193	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—CALCA—thyroid cancer	1.75e-05	0.0019	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CHST14—thyroid cancer	1.75e-05	0.00189	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—CALCA—thyroid cancer	1.74e-05	0.00189	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—SST—thyroid cancer	1.74e-05	0.00188	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—TSHR—thyroid cancer	1.74e-05	0.00188	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—CALCA—thyroid cancer	1.71e-05	0.00185	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PRKAR1A—thyroid cancer	1.71e-05	0.00185	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—CALCA—thyroid cancer	1.68e-05	0.00181	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MEN1—thyroid cancer	1.63e-05	0.00177	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—CDK1—thyroid cancer	1.59e-05	0.00172	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—CDK1—thyroid cancer	1.58e-05	0.00171	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—CDK1—thyroid cancer	1.55e-05	0.00168	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—CDK1—thyroid cancer	1.52e-05	0.00164	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PTCH1—thyroid cancer	1.48e-05	0.0016	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—HPGD—thyroid cancer	1.41e-05	0.00153	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—TSHR—thyroid cancer	1.38e-05	0.0015	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PRKAR1A—thyroid cancer	1.36e-05	0.00147	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—TSHR—thyroid cancer	1.35e-05	0.00146	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—SST—thyroid cancer	1.35e-05	0.00146	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PRKAR1A—thyroid cancer	1.33e-05	0.00144	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—TSHR—thyroid cancer	1.32e-05	0.00143	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PRKAR1A—thyroid cancer	1.3e-05	0.00141	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MEN1—thyroid cancer	1.3e-05	0.00141	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CALCA—thyroid cancer	1.3e-05	0.00141	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MEN1—thyroid cancer	1.27e-05	0.00138	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—NRG1—thyroid cancer	1.27e-05	0.00137	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MEN1—thyroid cancer	1.24e-05	0.00134	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CDK1—thyroid cancer	1.18e-05	0.00127	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PTCH1—thyroid cancer	1.18e-05	0.00127	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PTCH1—thyroid cancer	1.15e-05	0.00124	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—TERT—thyroid cancer	1.14e-05	0.00123	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PTCH1—thyroid cancer	1.12e-05	0.00122	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—HIF1A—thyroid cancer	1.09e-05	0.00118	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—SST—thyroid cancer	1.08e-05	0.00116	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—SST—thyroid cancer	1.05e-05	0.00114	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CALCA—thyroid cancer	1.04e-05	0.00112	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—SST—thyroid cancer	1.03e-05	0.00111	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CALCA—thyroid cancer	1.01e-05	0.0011	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CALCA—thyroid cancer	9.9e-06	0.00107	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—NRAS—thyroid cancer	9.59e-06	0.00104	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—NRG1—thyroid cancer	9.44e-06	0.00102	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CDK1—thyroid cancer	9.37e-06	0.00101	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CDK1—thyroid cancer	9.17e-06	0.000991	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—BRAF—thyroid cancer	9.01e-06	0.000974	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CDK1—thyroid cancer	8.96e-06	0.000969	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—TERT—thyroid cancer	8.48e-06	0.000917	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—KRAS—thyroid cancer	8.25e-06	0.000892	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—HIF1A—thyroid cancer	8.11e-06	0.000877	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—TPR—thyroid cancer	8.1e-06	0.000876	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	7.97e-06	0.000862	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—NRG1—thyroid cancer	7.52e-06	0.000813	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—NRG1—thyroid cancer	7.36e-06	0.000796	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—NRG1—thyroid cancer	7.19e-06	0.000778	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—NRAS—thyroid cancer	7.14e-06	0.000773	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—HRAS—thyroid cancer	7.01e-06	0.000758	CbGpPWpGaD
Pindolol—ADRB3—GPCR downstream signaling—AKT1—thyroid cancer	6.82e-06	0.000737	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—TERT—thyroid cancer	6.75e-06	0.00073	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—BRAF—thyroid cancer	6.72e-06	0.000726	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—TERT—thyroid cancer	6.61e-06	0.000714	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—CCND1—thyroid cancer	6.58e-06	0.000711	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—TERT—thyroid cancer	6.46e-06	0.000699	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—HIF1A—thyroid cancer	6.46e-06	0.000698	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—PTEN—thyroid cancer	6.35e-06	0.000686	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—HIF1A—thyroid cancer	6.32e-06	0.000683	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—AKT1—thyroid cancer	6.19e-06	0.00067	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—HIF1A—thyroid cancer	6.18e-06	0.000668	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—KRAS—thyroid cancer	6.15e-06	0.000665	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—SLC5A5—thyroid cancer	6.07e-06	0.000656	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—NRAS—thyroid cancer	5.69e-06	0.000615	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—NRAS—thyroid cancer	5.66e-06	0.000612	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—NRAS—thyroid cancer	5.57e-06	0.000602	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—NRAS—thyroid cancer	5.44e-06	0.000589	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—BRAF—thyroid cancer	5.35e-06	0.000578	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—BRAF—thyroid cancer	5.23e-06	0.000566	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—HRAS—thyroid cancer	5.23e-06	0.000565	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—BRAF—thyroid cancer	5.12e-06	0.000553	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—RXRA—thyroid cancer	5.1e-06	0.000551	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—AKT1—thyroid cancer	5.08e-06	0.00055	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CCND1—thyroid cancer	4.9e-06	0.00053	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—KRAS—thyroid cancer	4.9e-06	0.00053	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—KRAS—thyroid cancer	4.87e-06	0.000527	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—KRAS—thyroid cancer	4.79e-06	0.000518	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PTEN—thyroid cancer	4.73e-06	0.000512	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—KRAS—thyroid cancer	4.68e-06	0.000507	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—AKT1—thyroid cancer	4.62e-06	0.000499	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—TP53—thyroid cancer	4.33e-06	0.000468	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—NRAS—thyroid cancer	4.22e-06	0.000456	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—HRAS—thyroid cancer	4.16e-06	0.00045	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—HRAS—thyroid cancer	4.14e-06	0.000448	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—HRAS—thyroid cancer	4.07e-06	0.00044	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—AKT1—thyroid cancer	4.05e-06	0.000438	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—HRAS—thyroid cancer	3.98e-06	0.000431	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—AKT1—thyroid cancer	3.96e-06	0.000428	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CCND1—thyroid cancer	3.9e-06	0.000422	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—AKT1—thyroid cancer	3.87e-06	0.000419	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CCND1—thyroid cancer	3.82e-06	0.000413	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PTEN—thyroid cancer	3.77e-06	0.000407	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CCND1—thyroid cancer	3.73e-06	0.000404	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PTEN—thyroid cancer	3.69e-06	0.000399	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—AKT1—thyroid cancer	3.68e-06	0.000397	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—AKT1—thyroid cancer	3.66e-06	0.000396	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—KRAS—thyroid cancer	3.63e-06	0.000393	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PTEN—thyroid cancer	3.6e-06	0.00039	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—AKT1—thyroid cancer	3.6e-06	0.000389	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—AKT1—thyroid cancer	3.52e-06	0.00038	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—NRAS—thyroid cancer	3.36e-06	0.000363	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—NRAS—thyroid cancer	3.29e-06	0.000356	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—TP53—thyroid cancer	3.23e-06	0.000349	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PPARG—thyroid cancer	3.22e-06	0.000348	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—NRAS—thyroid cancer	3.22e-06	0.000348	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—HRAS—thyroid cancer	3.09e-06	0.000334	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—KRAS—thyroid cancer	2.89e-06	0.000313	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—KRAS—thyroid cancer	2.83e-06	0.000306	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—KRAS—thyroid cancer	2.77e-06	0.000299	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—AKT1—thyroid cancer	2.73e-06	0.000295	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—TP53—thyroid cancer	2.57e-06	0.000278	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PTGS2—thyroid cancer	2.53e-06	0.000274	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—TP53—thyroid cancer	2.52e-06	0.000272	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—TP53—thyroid cancer	2.46e-06	0.000266	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—HRAS—thyroid cancer	2.46e-06	0.000266	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—HRAS—thyroid cancer	2.41e-06	0.00026	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—HRAS—thyroid cancer	2.35e-06	0.000254	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PTEN—thyroid cancer	2.21e-06	0.000239	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—AKT1—thyroid cancer	2.17e-06	0.000235	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—AKT1—thyroid cancer	2.12e-06	0.00023	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—AKT1—thyroid cancer	2.08e-06	0.000225	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—AKT1—thyroid cancer	1.27e-06	0.000138	CbGpPWpGaD
